Results for this period
First quarter1 April 2026 to 30 June 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
The effects of remodeling existing stores, steady performance in the dispensing pharmacy and e-commerce businesses, a temporary increase in demand for daily necessities, strong sales of high-margin products such as luxury and other discretionary goods, and lower costs including payment processing fees because cashless payments fell below expectations. Sales of summer seasonal products were weak due to rainy weather and other factors, and inbound demand also declined.
No applicable matters
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 June 2026 |
| Net Sales | ¥215,331 million (YoY +3.7%) |
| Operating profit | ¥12,091 million (YoY -1.5%) |
| Ordinary income | ¥11,880 million (YoY -2.2%) |
| Profit attributable to owners of the parent | ¥8,017 million (YoY +0.9%) |
| Net income per share | ¥68.53 |
| Equity ratio | End of the current fiscal period 61.5 / End of previous period 60.1 |
| Total assets | ¥465,286 million |
| Net assets | ¥286,272 million |
| Full-year earnings forecast | Net Sales ¥876,000 million (YoY +4.0%) / Operating profit ¥48,800 million (YoY +4.2%) / Ordinary income ¥48,100 million (YoY +4.1%) / Net income ¥32,150 million (YoY +2.4%) |
| Annual Dividend Forecast | ¥131 → ¥132（+0.8%） |
| Segment revenue | Drugstore Business ¥137,114 million (YoY +2.9%), Discount store business ¥94,046 million (YoY +4.5%) |
| Segment profit | Drugstore Business ¥6,627 million, Discount store business ¥5,463 million (YoY +0.5%) |
| Depreciation and amortization | ¥4,656 million |
| Impairment loss | ¥6 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of investment securities ¥33 million, Government subsidies ¥25 million, Gain on cancellation of insurance policies ¥27 million, Other ¥0 million / Extraordinary loss Impairment Losses ¥6 million, Loss on Disposal of Fixed Assets ¥15 million, Loss on reduction of fixed assets ¥23 million, Losses from natural disasters ¥0 million, Loss on cancellation of insurance policies ¥11 million |
| Disclosure regarding the going concern assumption | No applicable matters |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 / Excluded 0 / Company name Not disclosed |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | No |
| Issued Shares at Period-End | 119,331,184 |
| Treasury Shares at Period-End | 2,348,285 |
| Factors Behind Changes in Business Performance | The effects of remodeling existing stores, steady performance in the dispensing pharmacy and e-commerce businesses, a temporary increase in demand for daily necessities, strong sales of high-margin products such as luxury and other discretionary goods, and lower costs including payment processing fees because cashless payments fell below expectations. Sales of summer seasonal products were weak due to rainy weather and other factors, and inbound demand also declined. |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the drugstore business, sales were boosted by the effects of remodeling existing stores, steady performance in the dispensing pharmacy and e-commerce businesses, and a temporary increase in demand for daily necessities amid concerns about petroleum shortages. These factors were offset by weak sales of summer seasonal products due to rainy weather and other factors, as well as a decline in inbound demand. In the discount store business, the company cited strong sales of high-margin products such as luxury and other discretionary goods, and lower costs including payment processing fees because cashless payments fell below expectations.